B1

One gastro-resistant tablet contains: thiamine nitrate (Vit. B1) 15 mg riboflavin (Vit. B2) 15 mg, nicotinamide 50 mg, pyridoxine hydrochloride (Vit. B6) 10 mg, calcium pantothenate 25 mg, cyanocobalamin 10 mg(in the form of Vit. B 12 0.1% WS), biotin 150 mg.

Prophylactic administration of the medicine is indicated in case of increased need for B vitamins (e.g. pregnancy, lactation), insufficient absorption( digestive disorders), food imbalances( uniform diets), i.e. in all cases where the body may not take sufficient amounts of vitamin B. Glossitis, cheilitis, anorexia (for example in the course of febrile conditions) with weight loss, child growth retardation, asthenia, in case of prolonged antibiotic therapy, intestinal absorption disorders in the course of gastro-enteric conditions. As an adjuvant in liver diseases and neuritis, treatment of the After-Effects of chronic alcoholismimputable to a vitamin deficiency

The medicine is indicated in adults and children over 12 years of age. As a cure: 2-3 gastro-resistant tablets per day, attack dose in case of symptoms of marked deficiency or insufficient absorption (e.g. following diarrhoea, enteritis, steatorrhea, sprue). In antibacterial treatments: as a prophylactic, 1 gastro-resistant tablet per day. The drug is not recommended in children under 12 years of age as there are no efficacy and safety data available for this age group. Method of administration: oral use. Swallow the gastro-resistant tablets without chewing them, with a little liquid

Hypersensitivity to the active substance or to any of the listed excipients.

See also:
What other drugs will affect B1?

Interactions for B1

Loop Diuretics,

Oral Contraceptives, Stavudine, Tricyclic Antidepressants

The adverse reactions listed below have been identified during the period following the approval of the medicinal product. As these reactions result from spontaneous signals, it is not possible to estimate their frequency. Gastrointestinal disorders: gastrointestinal and abdominal pain, constipation, vomiting, diarrhoea, nausea. Immune system disorders: allergic reaction, anaphylactic reaction, anaphylactic shock. Hypersensitivity reactions with corresponding laboratory and clinical manifestations include asthmatic syndrome, mild to moderate skin, respiratory, gastrointestinal and/or cardiovascular reactions. Symptoms may include: rash, hives, facial oedema, erythema, itching, wheezing, cardio-respiratory distress and severe reactions including anaphylactic shock. If an allergic reaction occurs, discontinue treatment. Nervous system disorders: headache. Renal and urinary disorders: chromaturia. The reporting of suspected adverse reactions that occur after authorisation of the medicinal product is important as it allows continuous monitoring of the benefit/risk ratio of the medicinal product